We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

Citations Search

Sort By:

J. Biol. Chem. 292, 14240-14249. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate. 2017

Koppula, P., Zhang, Y., Shi, J., Li, W. and Gan, B.

Notes: The Glutamate-Glo™ Assay was used to measure intracellular glutamate levels. Briefly, the cells were seeded in a 96-well plate, followed by glucose starvation as described above. Cells were then washed with ice-cold PBS and lysed with 0.6 N HCl. The lysing reagent was inactivated using 1 M Tris base. Glutamate dehydrogenase uses the glutamate present in the lysate and NAD+ to produce αKG and NADH. In the presence of NADH, a pro-luciferin reductase substrate is converted by reductase to luciferin, which is then used by Ultra-Glo™ recombinant luciferase to produce light. (4998)

Expand Full Notes »

SLAS Discov 4, 366–377. Bioluminescent Assays for Glucose and Glutamine Metabolism: High-Throughput Screening for Changes in Extracellular and Intracellular Metabolites 2017

Leippe, D., Sobol, M., Vidugiris, G., Cali, J.J. and Vidugiriene, J.

Notes: The authors of this paper describe bioluminescent glucose, lactate, glutamine and glutamate assays suitable for high-throughput analysis of two major metabolic pathways in cancer cells: glycolysis and glutaminolysis. (4769)

Expand Full Notes »